Accéder au contenu
Merck

Efficiency of lyticase (bacterial enzyme) in experimental candidal vaginitis in mice.

Bulletin of experimental biology and medicine (2010-12-18)
N P Sachivkina, E G Kravtsov, E A Wasileva, I V Anokchina, M V Dalin
RÉSUMÉ

Lyticase (a bacterial enzyme) was tested as a new antimycotic drug. Of all objects studied, Cellulomonas cellulans AC-870 strain proved to be most productive for this enzyme. A technology for lyticase isolation and purification was proposed. An experimental model of recurrent vaginal candidiasis was created. The model includes combined antibiotic and estradiol therapy. Antimycotic effect of lyticase on the model of recurrent vaginal candidiasis in mice was demonstrated.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
β-(1→3)-D-Glucanase from Helix pomatia, ≥0.2 U/mg